Skip to main content
Year archive

AFT PHARMACEUTICALS LIMITED — 2023 filings

All 36 regulatory filings released by AFT PHARMACEUTICALS LIMITED (AFP) in 2023, sourced directly from the official regulator.

36 Filings
2023 Period
2023 filings (36)
Filing Released Lang
AFT broadens R&D pipeline with new product candidate 2 pages 122.1KB
Regulatory Filings
2023-12-21 English
FY2024 Interim 1 page 158.0KB
Interim / Quarterly Report
2023-11-22 English
FY2024 Interim 4 pages 201.7KB
Interim / Quarterly Report
2023-11-22 English
FY2024 Interim 23 pages 5.1MB
Investor Presentation
2023-11-22 English
AFT Crystaderm antiseptic approved for sale in China 2 pages 118.0KB
Regulatory Filings
2023-11-20 English
AFP welcomes US FDA approval for sale of Maxigesic IV 2 pages 131.4KB
Regulatory Filings
2023-10-17 English
AFP half year interim results on Thursday November 23 2023 1
Report Publication Announcement
2023-10-08 English
AFT appoints Andrew Lane as independent director 2 pages 118.2KB
Board/Management Information
2023-09-27 English
Retirement of Jon Lamb 1 page 114.0KB
Board/Management Information
2023-09-27 English
Disclosure of Directors and Senior Managers Relevant Interes 2 pages 406.7KB
Director's Dealing
2023-09-17 English
AFT Orphan Pharmaceuticals judgment 3 pages 153.2KB
Legal Proceedings Report
2023-08-28 English
Chairs Address 5 pages 173.0KB
AGM Information
2023-08-03 English
Presentation 40 pages 5.6MB
Regulatory Filings
2023-08-03 English
Intention to Retire 1 page 114.1KB
Board/Management Information
2023-08-03 English
Results of 2023 Annual Shareholder Meeting 1 page 1
Declaration of Voting Results & Voting Rights Announcements
2023-08-03 English
AFT signs new licensing agreement for ZENEO Midazolam 4 pages 281.0KB
Capital/Financing Update
2023-07-20 English
AFT extends e-commerce presence into Amazon US 3 pages 137.1KB
Regulatory Filings
2023-07-10 English
Notice of Annual Meeting of Shareholders 2023 3 pages 441.6KB
AGM Information
2023-06-29 English
Dividend/Distribution - AFP 4 pages 25.0KB
Notice of Dividend Amount
2023-05-29 English
Annual Meeting and Closing Date for Director Nominations 1
AGM Information
2023-05-25 English
FY2023 App2 1 page 192.1KB
Earnings Release
2023-05-21 English
Market release FY2023 5 pages 183.3KB
Annual Report
2023-05-21 English
FY2023 Presentation 25 pages 4.9MB
Investor Presentation
2023-05-21 English
FY2023 Annual Report 86 pages 8.9MB
Regulatory Filings
2023-05-21 English
Governance Statement 20 pages 1.8MB
Governance Information
2023-05-21 English
FY2023 Modern Slavery 7 pages 958.3KB
Environmental & Social Information
2023-05-21 English
FY2023 Distribution notice 2 pages 149.6KB
Notice of Dividend Amount
2023-05-21 English
notice of issue of options 2 pages 178.9KB
Share Issue/Capital Change
2023-05-21 English
to announce full year results on Monday May 22 2023 1
Report Publication Announcement
2023-05-03 English
US FDA sets PDUFA date for Maxigesic IV 1 page 148.
Regulatory Filings
2023-04-30 English
AFT submits Maxigesic IV packaging data to the US FDA 2 pages 128.5KB
Regulatory Filings
2023-04-17 English
NEW LICENSING AND APPROVALS 2 pages 107.5KB
Capital/Financing Update
2023-03-26 English
Maxigesic Rapid tablets gain US FDA approval 2 pages 106.3KB
Regulatory Filings
2023-03-01 English
AFT to develop antibiotic eye drop 3 pages 122.7KB
Capital/Financing Update
2023-02-01 English
AFT announces Maxigesic IV distribution agreement for nine 2 pages 158.9KB
Capital/Financing Update
2023-01-23 English
2023 New Year letter to investors 6 pages 187.4KB
Management Reports
2023-01-08 English